IMO, $500K is the number. Sounds low, right? Don't worry, there's a caveat.
They did $2.5M in 2020 and $700K in 2019. The revenue stream(s) that make up those figures come from cleaning (hospital acquired infections) and CoVid. Going forward, CoVid will diminish and cleaning / disinfecting will be what it always what, but with a larger footprint.
It appears there is an uncommunicated move afoot to transition the company from "what it was" to more focused on Oil & Gas and Agriculture.
If they can tell the story (big ask) of why the company will succeed in this transition, $500K ($2M per year in annual sales) is a decent starter position.
But the new focus / revenue streams have to have much greater potential over the existing one(s), maybe even an order of magnitude higher, to justify the current market cap (~$13.5M or ~$24M fully diluted).
Cleaning the fooking cap like they said they already did (447M warrants still existing) would go a long ways also.
jesuslovzu My perspective is that the first quarter will be very weak but that revenues may or may not improve strongly during the remainder of the year. I have seen little suggesting good revenues during the first quarter. Later a lot will hinge on oil & gas and perhaps the UK.
Here is a guess: “Breakeven” = $0.017 @ $600K Revenue Q1 (= no improvement over 2020 annual/quarterly run rate) $0.04 at $1.25 M $0.05 at $1.5 M $0.06 at $1.75 M $0.07 at $2.0 M $0.08 at $2.25 M $0.09 at $2.5M (= $10 M annual run rate)